ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 269,33
-0,98%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Day One Biopharmaceuticals Inc (DAWN)

  7. Day One Biopharmaceuticals Inc (DAWN) Actualités

DAWN Day One Biopharmaceuticals Inc

17,25
-0,32 (-1,82%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Day One Biopharmaceuticals Inc DAWN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,32 -1,82% 17,25 06:00:06
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
18,00 17,13 18,00 17,17 17,57
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/3/202422:19EDGAR2Form 8-K - Current report
29/2/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
21/2/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:51EDGAR2Form 144 - Report of proposed sale of securities
17/1/202414:25EDGAR2Form 8-K - Current report
10/1/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:30EDGAR2Form 8-K - Current report
04/1/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/11/202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202313:07EDGAR2Form 8-K - Current report
17/11/202300:24EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:07EDGAR2Form 8-K - Current report
06/11/202322:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:30EDGAR2Form 8-K - Current report
30/10/202315:54DJNDay One Biopharmaceuticals Shares Rally on FDA Priority..
30/10/202313:58DJNDay One Gets FDA Priority Review of Tovorafenib in Pediatric..
30/10/202313:12EDGAR2Form 8-K - Current report
20/10/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
14/9/202323:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/9/202314:35EDGAR2Form 8-K - Current report
18/8/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202314:06EDGAR2Form 8-K - Current report
07/8/202322:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:30EDGAR2Form 8-K - Current report
06/7/202301:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202313:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..

Dernières Valeurs Consultées

NASDAQ
DAWN
Day One Biopharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés